Concepedia

Eileen Turcott

ET

Statistics

Publications

7

Citations

1.1K

H-Index

7

Active since

2003

Affiliations

Seagen (United States)(Current)

University of Washington

Celltechgen (United States)

Target (United States)

Eileen Turcott is an author at Seagen (United States) specializing in antibody characterization, oncology, and molecular oncology.

Publications per year

2003–2008

7

Publications

7

Sclerostin promotes the apoptosis of human osteoblastic cells: a novel regulation of bone formation

May Kung Sutherland, James C. Geoghegan, Changpu Yu et al. · Bone · 2004 · 239 citations

, , +14

Engineered antibody-drug conjugates with defined sites and stoichiometries of drug attachment

Charlotte F. McDonagh, Eileen Turcott, Lori Westendorf et al. · Protein Engineering Design and Selection · 2006 · 237 citations · Full text

, , +17

Gene Expression Analyzed by High-resolution State Array Analysis and Quantitative Proteomics

Vivian L. MacKay, Xiaohong Li, Mark R. Flory et al. · Molecular & Cellular Proteomics · 2004 · 204 citations · Full text

, , +13

Sclerostin Inhibition of Wnt-3a-induced C3H10T1/2 Cell Differentiation Is Indirect and Mediated by Bone Morphogenetic Proteins

David G. Winkler, May S.K. Sutherland, Ethan W. Ojala et al. · Journal of Biological Chemistry · 2004 · 164 citations · Full text

, , +16

Engineered anti-CD70 antibody with multiple effector functions exhibits in vitro and in vivo antitumor activities

Julie A. McEarchern, Ezogelin Oflazoglu, Leigh Francisco et al. · Blood · 2006 · 101 citations · Full text

, , +15

1–5 of 7